ADACEL PACKAGE INSERT PDF

The second dose of Hep B vaccine was given weeks after the first dose. Serum samples were obtained prior to and weeks after Adacel vaccine administration, as well as weeks after the 2nd dose of Hep B for all participants. No interference was observed in the immune responses to any of the vaccine antigens when Adacel and Hep B vaccines were given concurrently or separately. Sera were obtained prior to and weeks after Adacel vaccine, as well as weeks after the TIV. Indications and Usage for Adacel TDAP Adacel vaccine is indicated for active booster immunization for the prevention of tetanus, diphtheria and pertussis as a single dose in persons 11 through 64 years of age.

Author:Togore Akill
Country:Azerbaijan
Language:English (Spanish)
Genre:Finance
Published (Last):8 April 2010
Pages:336
PDF File Size:4.41 Mb
ePub File Size:13.6 Mb
ISBN:741-5-70750-753-4
Downloads:33666
Price:Free* [*Free Regsitration Required]
Uploader:Dogis



Adacel is approved for use in individuals 10 through 64 years of age. The vial stopper is not made with natural rubber latex. Syncope fainting can occur in association with administration of injectable vaccines, including Adacel.

Procedures should be in place to prevent falling injury and manage syncopal reactions. After the first and second dose of Adacel, the most frequently reported solicited reactions were pain, swelling, and erythema at the injection site; headache, body ache or muscle weakness, tiredness, myalgia, and malaise.

Other adverse reactions may occur. Vaccination with Adacel may not protect all individuals. Please see the full Prescribing Information for Adacel vaccine. References: 1. Adult immunization schedule. Updated February 7, Accessed June 25, Adacel vaccine [Prescribing Information]. Current prevalence rate of latex allergy: why it remains a problem?

J Occup Health. US Census Bureau. US and world population clock. Updated January 18, Accessed August 27, General immunization practices. Elsevier Saunders, Sanofi Pasteur Inc. Data on File

DIN 17245 PDF

Adacel TDaP: Package Insert and Label Information

Adacel is approved for use in individuals 10 through 64 years of age. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If either of these conditions exist, the vaccine should not be administered. Withdraw the 0. Adacel should not be combined through reconstitution or mixed with any other vaccine.

DRAFT RUU PANGAN PDF

Adacel TDAP

.

Related Articles